8-K: Masimo Explores Sale of Consumer Business for $850M-$950M, Mulls Spin-Off

Masimo is in discussions to sell a majority stake in its consumer business for a potential price between $850 million and $950 million, while also considering a spin-off.

Summary

• Masimo is exploring the sale of a majority stake in its consumer audio and health businesses to a potential joint venture partner.
• The potential purchase price is currently estimated to be between $850 million and $950 million on a cash and debt free basis.
• This valuation is lower than the initial term sheet, and Masimo intends to negotiate for a higher price.
• The deal includes a short-term extension of the exclusivity period through mid-August 2024 to allow other potential partners to conduct due diligence.
• Masimo is also considering a spin-off of its consumer business into a new public company as an alternative.
• The terms of the potential joint venture are still under discussion, including intellectual property rights and the handling of ongoing litigation with Apple.
• The final terms of any transaction may differ materially from what has been described.

Sentiment

Score: 5

Explanation: The document presents a mixed picture. While the potential sale of the consumer business could be positive, the lower valuation and ongoing negotiations introduce uncertainty. The consideration of a spin-off adds complexity. The sentiment is neutral to slightly negative due to the lower valuation and the risks associated with the transaction.

Positives

• The potential sale of the consumer business could provide a significant cash infusion for Masimo.
• The company is actively exploring options to maximize the value of its consumer business, including a potential spin-off.
• Masimo is being advised by Morgan Stanley and outside counsel, suggesting a professional approach to the transaction.
• The potential joint venture could allow Masimo to focus on its core healthcare business.

Negatives

• The current purchase price range of $850 million to $950 million is lower than the initial term sheet.
• The deal is still subject to further negotiations, due diligence, and approvals, creating uncertainty.
• The terms of the intellectual property license are still under discussion, which could impact the value of the deal.
• The potential joint venture could divert management's attention from ongoing business operations.

Risks

• The potential joint venture may not be completed or may be delayed.
• The final terms of the deal may differ significantly from the current proposal.
• The company may not receive the required approvals from the board or regulatory authorities.
• The announcement of the potential joint venture could negatively impact Masimo's ability to retain key employees.
• The potential joint venture may not achieve its intended benefits.
• There are risks related to evolving legal, regulatory, and tax regimes.

Future Outlook

Masimo is actively engaged in discussions regarding the potential joint venture and is also considering a spin-off of its consumer business. The final terms of any transaction are subject to further negotiations, due diligence, and approvals. The company does not commit to updating any forward looking statements.

Management Comments

• Masimo's management had been engaged in discussions regarding a potential investment in Masimo.
• Masimo has proposed to license certain intellectual property rights to the Potential JV for use solely within the consumer field.
• Masimo intends to negotiate for a higher price than the current offer.
• The Board continues to evaluate the optimal value maximizing structure of the separation of Masimos consumer business.

Industry Context

The potential sale or spin-off of Masimo's consumer business reflects a trend of companies focusing on core competencies and divesting non-core assets. This move could allow Masimo to concentrate on its healthcare technology business, which is likely more profitable and has higher growth potential.

Comparison to Industry Standards

• The valuation range of $850 million to $950 million for Masimo's consumer business is within the range of similar transactions in the consumer electronics and health tech sectors.
• Companies like Fitbit (acquired by Google) and Withings have seen similar valuations in the past, although those companies were more established in the consumer health space.
• The potential spin-off of the consumer business is a strategy used by other large companies to unlock value and allow each business to focus on its specific market.
• The negotiation of intellectual property rights is a common aspect of these types of transactions, and the outcome will be critical to the long-term success of the deal.

Legal Proceedings

• Masimo has proposed to retain the litigation with Apple.

Stakeholder Impact

• Shareholders may be impacted by the potential sale or spin-off of the consumer business.
• Employees in the consumer business may be affected by the transaction.
• Customers of the consumer business may experience changes as a result of the transaction.
• The potential joint venture could impact Masimo's relationships with its business counterparties.

Next Steps

• Masimo and the potential JV partner will continue discussions regarding the terms of the potential joint venture.
• The potential JV partner will conduct further due diligence.
• Masimo will negotiate for a higher purchase price.
• The company will seek necessary approvals from the Board and regulatory authorities.
• Masimo will continue to evaluate the possibility of a spin-off of the consumer business.

Key Dates

Keywords

consumer business, joint venture, spin-off, acquisition, intellectual property, due diligence, Masimo, healthcare, valuation